Clear Labs
PrivateLast Round
Series D
Jan 13, 2025
Total Funding Raised
$130.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Clear Labs is a biotechnology company that provides a fully automated, end-to-end next-generation sequencing platform for clinical and applied diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clear Labs Comparables
Compare Clear Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EW Group | 71% | |
| GenoScreen | 69% | |
| Rheonix | 69% |
Clear Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jan 13, 2025 | ||||
| Series C | May 26, 2021 | ||||
| VC Round | May 14, 2020 | ||||
| Series B Extension | Oct 30, 2018 | ||||
| Series B | Dec 13, 2016 | ||||
Series A | Sep 15, 2015 |
Key People
Founding team and executive leadership
Clear Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series C, Series D, VC Round |
| GV | Series C, Series B, VC Round, Series D |
| NimbleVentures | Series D |
| Khosla Ventures | Series B Extension, Series C, Series B, VC Round, Series D, Series A |
| Morgan Stanley | Series D, Series C |
| Dentsu Ventures | Series B Extension |
| HBM Healthcare Investments | Series C, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 14, 2025
Collaborating with global life sciences company Labcorp.
- Nov 13, 2025
Presented new automated workflow at the AMP Annual Meeting.
Clear Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Clear Labs's valuation, stock price, and market status.
Is Clear Labs a public or private company?
Clear Labs is a private company.
What is the current stock price of Clear Labs?
Clear Labs is a private company with no public stock price. No recent secondary market data is available.
How much is Clear Labs worth (valuation)?
Valuation information for Clear Labs is not publicly available.
Can I buy Clear Labs stock?
Clear Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Clear Labs's last funding round?
Clear Labs's most recent funding round was Series D on January 13, 2025.
Who are the main investors in Clear Labs?
Key investors in Clear Labs include T. Rowe Price, Wing Venture Capital, Menlo Ventures.
Will Clear Labs IPO soon?
No public IPO plans have been announced for Clear Labs.
How can I track Clear Labs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Clear Labs's secondary market activity and sign up for updates.